The pharmaceutical landscape is seeing a shift with the introduction of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to administering glucagon-like peptide-1 drugs https://albiezuol012592.vblogetin.com/47023728/glp-1-patches-a-novel-way-to-treat-blood-sugar